AxoGen (AXGN)
(Delayed Data from NSDQ)
$6.63 USD
+0.11 (1.69%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $6.62 -0.01 (-0.15%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum A VGM
Income Statements
Fiscal Year end for AxoGen, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 159 | 139 | 127 | 112 | 107 |
Cost Of Goods | 31 | 24 | 23 | 22 | 17 |
Gross Profit | 128 | 114 | 104 | 91 | 89 |
Selling & Adminstrative & Depr. & Amort Expenses | 149 | 144 | 130 | 114 | 121 |
Income After Depreciation & Amortization | -21 | -30 | -25 | -23 | -31 |
Non-Operating Income | 3 | 1 | 0 | 0 | 2 |
Interest Expense | 3 | 1 | 1 | 1 | 0 |
Pretax Income | -22 | -29 | -27 | -24 | -29 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -22 | -29 | -27 | -24 | -29 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -22 | -29 | -27 | -24 | -29 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -15 | -24 | -20 | -20 | -29 |
Depreciation & Amortization (Cash Flow) | 6 | 6 | 6 | 4 | 3 |
Income After Depreciation & Amortization | -21 | -30 | -25 | -23 | -31 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 42.88 | 42.08 | 41.22 | 39.97 | 39.24 |
Diluted EPS Before Non-Recurring Items | -0.51 | -0.67 | -0.59 | -0.60 | -0.68 |
Diluted Net EPS (GAAP) | -0.51 | -0.69 | -0.65 | -0.60 | -0.74 |
Fiscal Year end for AxoGen, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 42.92 | 41.27 | 38.16 | 36.66 |
Cost Of Goods | NA | 9.16 | 8.04 | 7.23 | 6.71 |
Gross Profit | NA | 33.76 | 33.23 | 30.93 | 29.96 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 36.96 | 37.25 | 37.83 | 37.30 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -3.20 | -4.02 | -6.90 | -7.34 |
Non-Operating Income | NA | 1.15 | 0.76 | 0.39 | 0.28 |
Interest Expense | NA | 1.84 | 0.83 | 0.15 | 0.02 |
Pretax Income | NA | -3.89 | -4.09 | -6.66 | -7.07 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -3.89 | -4.09 | -6.66 | -7.07 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -3.89 | -4.09 | -6.66 | -7.07 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 43.05 | 43.02 | 42.86 | 42.57 |
Diluted EPS Before Non-Recurring Items | NA | -0.09 | -0.10 | -0.16 | -0.17 |
Diluted Net EPS (GAAP) | NA | -0.08 | -0.10 | -0.16 | -0.17 |